24/7 Patient Assistance: 760-405-8205

Mark Buyyounouski, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information

    Dr. Mark Buyyounouski is a radiation oncology specialist in Stanford, California and works at Stanford Hospital and Clinics. He got his diploma from Rutgers New Jersey Medical School and did his internship at St Barnabas Medical Center. The doctor completed his residency program in radiation oncology at Fox Chase Cancer Center. Dr. Mark Buyyounouski is certified in radiation oncology and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Rutgers New Jersey

    Medical School

    dept_icon

    St Barnabas Medical Center

    Internship

    dept_icon

    Fox Chase Cancer Center

    Residency

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Stanford Health Care

    Languages: English/Spanish

    (650) 723-4000

    Stanford University, 401 Quarry Road

    Stanford, California 94305

    Read More
  • Publications & Memberships

    Dr. Mark Buyyounouski has contributed to 3 publications.

    SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk p...

    Kishan, A. U.,Wang, P. C.,Upadhyaya, S. K.,Hauswald, H.,Demanes, D. J.,Nickols, N. G.,Kamrava, M.,Sadeghi, A.,Kupelian, P. A.,Steinberg, M. L.,Prionas, N. D.,Buyyounou...; Pract Radiat Oncol. 2016 Feb 07.

    See more >>

    The case for prostate brachytherapy in the Affordable Care Act era.

    Durkee, B. Y.,Buyyounouski, M. K.; Int. J. Radiat. Oncol. Biol. Phys.. 2015 Feb 15.

    See more >>

    Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.

    Miller, S. M.,Hudson, S. V.,Hui, S. K.,Diefenbach, M. A.,Fleisher, L.,Raivitch, S.,Belton, T.,Roy, G.,Njoku, A.,Scarpato, J.,Viterbo, R.,Buyyounouski, M.,Denlinger, C....; J Cancer Surviv. 2015 Feb 24.

    See more >>